Latest AI and machine learning research in diabetes for healthcare professionals.
The use of artificial intelligence (AI) in diabetes management is emerging as a promising solution to improve the monitoring and personalization of therapies. However, the integration of such technologies in the clinical setting poses significant challenges related to safety, security, and compliance with sensitive patient data, as well as the potential direct consequences on patient health. This ...
AIM: We aimed to identify the characteristics of patients with diabetes who can derive cognitive benefits from intensive blood pressure (BP) treatment using machine learning methods.
INTRODUCTION: The incidence of gestational diabetes mellitus (GDM) in Australia has tripled in the last 20 years. Consequently, over 40 000 pregnancie...
BACKGROUND: Diabetic peripheral neuropathy (DPN) is a common complication of diabetes, and its early identification is crucial for improving patient o...
BACKGROUND: IgA nephropathy (IgAN) is a leading cause of renal failure, but its pathogenesis remains unclear, complicating diagnosis and treatment. Th...
OBJECTIVES: Type 2 diabetes mellitus is a disease with a rising prevalence worldwide. Person-centered treatment factors, including comorbidities and t...
OBJECTIVES: Adipsin and leptin are adipokines that link adipose tissue dysfunction and increased fat accumulation to obesity-related metabolic disorde...
INTRODUCTION: Lactic acid bacteria are prized for their probiotic benefits and gut health improvements. This study assessed five LAB isolates from Nee...
INTRODUCTION: Diabetic retinopathy is a significant microvascular disorder and the leading cause of vision impairment in working-age individuals. Hype...
BACKGROUND: Accurate fasting plasma glucose (FPG) trend prediction is important for management and treatment of patients with type 2 diabetes mellitus...
: The use of artificial intelligence (AI) chatbots for obtaining healthcare advice is greatly increased in the general population. This study assessed...
Progress in developing therapies for the maintenance of endogenous insulin secretion in, or the prevention of, type 1 diabetes has been hindered by li...
AIMS: Automated retinal image analysis using Artificial Intelligence (AI) can detect diabetic retinopathy as accurately as human graders, but it is no...
PPG signals are a new means of non-invasive detection of blood glucose, but there are still shortcomings of poor time adaptability and low prediction ...
INTRODUCTION: Calcific aortic valve disease (CAVD) is increasingly prevalent among the aging population, and there is a notable lack of drug therapies...
Therapeutic proteins, the fastest growing class of pharmaceuticals, are subject to rapid proteolytic degradation in vivo, rendering them inactive. Sop...
Diabetic Retinopathy (DR) stands as a significant global cause of vision impairment, underscoring the critical importance of early detection in mitiga...
BACKGROUND: Diabetes mellitus (DM) is a chronic disease prevalent worldwide, requiring a multifaceted analytical approach to improve early detection a...
BACKGROUND: The incidence and mortality of first-ever strokes have risen sharply, especially in the intensive care unit (ICU). Emerging surrogate for ...
Nocturnal hypoglycemia is a critical problem faced by diabetic patients. Failure to intervene in time can be dangerous for patients. The existing earl...